ALIGOS THERAPEUTICS INC
ALGS·01626L204·US·Common Stock·Healthcare - Biotechnology-Activist
ALGS (ALIGOS THERAPEUTICS INC) is held by 27 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($3.1M), MARSHALL WACE, LLP ($2M), BANK OF AMERICA CORP /DE/ ($1.7M). Net institutional sentiment: Mixed.
27
Holders
$13.8M
Total Value
48% (25)
Consensus
12 buying - 13 selling
13F: Insider & Congress:
Who's Trading
ActivistLMLawrence M. Blatt5.6%Jun 24, 2026
ActivistLMLawrence M. Blatt5.1%May 15, 2026
ActivistSISio Capital Management, LLC5.5%Feb 11, 2026
ActivistADAdage Capital Management, L.P.3.9%Aug 12, 2025
ActivistECEcoR1 Capital, LLC3.9%May 15, 2025
ActivistLMLawrence M. Blatt, Ph.D.3.2%Mar 12, 2025
Showing 1-20 of 32
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer